60 related articles for article (PubMed ID: 31016642)
1. CTNNB1 mutation-driven hybrid tumor: desmoid fibromatosis with an unusual associated epithelioid component arising in association with a neuromuscular choristoma.
Zheng X; He X; Lu Y; Chen C; Zhang H
Virchows Arch; 2024 Apr; 484(4):715-720. PubMed ID: 38183458
[TBL] [Abstract][Full Text] [Related]
2. Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
Braggio DA; Costas C de Faria F; Koller D; Jin F; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Horrigan SK; Han R; Larson JL; Strohecker AM; Pollock RE
PLoS One; 2022; 17(10):e0276047. PubMed ID: 36240209
[TBL] [Abstract][Full Text] [Related]
3. Active surveillance and emerging medical treatment options for desmoid: when and for whom?
Bonvalot S; Miah A; Kasper B
Curr Opin Oncol; 2024 May; ():. PubMed ID: 38726846
[TBL] [Abstract][Full Text] [Related]
4. The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
Desmoid Tumor Working Group
Eur J Cancer; 2020 Mar; 127():96-107. PubMed ID: 32004793
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Management of Desmoid Fibromatosis of the Breast.
Kangas-Dick A; Ali M; Poss M; Khoury T; Takabe K
World J Oncol; 2024 Jun; 15(3):394-404. PubMed ID: 38751692
[TBL] [Abstract][Full Text] [Related]
6. Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities.
Esperança-Martins M; Melo-Alvim C; Dâmaso S; Lopes-Brás R; Peniche T; Nogueira-Costa G; Abreu C; Luna Pais H; de Sousa RT; Torres S; Gallego-Paez LM; Martins M; Ribeiro L; Costa L
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568749
[TBL] [Abstract][Full Text] [Related]
7. [B3 lesions of the breast: histological, clinical, and epidemiological aspects : Update].
Varga Z; Sinn P; Lebeau A
Pathologie (Heidelb); 2023 Feb; 44(1):5-16. PubMed ID: 36635403
[TBL] [Abstract][Full Text] [Related]
8. Bilateral breast desmoid-type fibromatosis, case report and literature review.
Hennuy C; Defrère P; Maweja S; Thiry A; Gennigens C
Gland Surg; 2022 Nov; 11(11):1832-1841. PubMed ID: 36518797
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls in breast pathology.
Quinn C; Maguire A; Rakha E
Histopathology; 2023 Jan; 82(1):140-161. PubMed ID: 36482276
[TBL] [Abstract][Full Text] [Related]
10. Spindle cell lesions of the breast: a diagnostic approach.
Rakha EA; Brogi E; Castellano I; Quinn C
Virchows Arch; 2022 Jan; 480(1):127-145. PubMed ID: 34322734
[TBL] [Abstract][Full Text] [Related]
11. Mimickers of breast malignancy: imaging findings, pathologic concordance and clinical management.
Guirguis MS; Adrada B; Santiago L; Candelaria R; Arribas E
Insights Imaging; 2021 Apr; 12(1):53. PubMed ID: 33877461
[TBL] [Abstract][Full Text] [Related]
12. Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery.
Lorenzen J; Cramer M; Buck N; Friedrichs K; Graubner K; Lühr CS; Lindner C; Niendorf A
Breast Care (Basel); 2021 Feb; 16(1):77-84. PubMed ID: 33708054
[TBL] [Abstract][Full Text] [Related]
13. Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature.
Boland MR; Nugent T; Nolan J; O'Mahony J; O'Keeffe S; Gillham CC; Maguire A; Geraghty J; McCartan D; Evoy D; Prichard RS; McDermott EW; Alazawi D; Boyle TJ; Connolly EM
Breast Cancer; 2021 Jan; 28(1):168-174. PubMed ID: 32780320
[TBL] [Abstract][Full Text] [Related]
14. Breast desmoid tumor management in France: toward a new strategy.
Duazo-Cassin L; Le Guellec S; Lusque A; Chantalat E; Laé M; Terrier P; Coindre JM; Boulet B; Le Boulc'h M; Gangloff D; Meresse T; Chaput B; Al Ali A; Rimareix F; Bonvalot S; Vaysse C
Breast Cancer Res Treat; 2019 Jul; 176(2):329-335. PubMed ID: 31016642
[TBL] [Abstract][Full Text] [Related]
15. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
[TBL] [Abstract][Full Text] [Related]
16. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
[TBL] [Abstract][Full Text] [Related]
17. Toward a new strategy in desmoid of the breast?
Roussin S; Mazouni C; Rimareix F; Honoré C; Terrier P; Mir O; Dômont J; Le Péchoux C; Le Cesne A; Bonvalot S
Eur J Surg Oncol; 2015 Apr; 41(4):571-6. PubMed ID: 25639193
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
